FDA — authorised 10 December 1997
- Application: ANDA074712
- Marketing authorisation holder: CUMBERLAND PHARMS
- Status: supplemented
FDA authorised Kristalose on 10 December 1997
Yes. FDA authorised it on 10 December 1997; FDA has authorised it.
CUMBERLAND PHARMS holds the US marketing authorisation.